SCIDOT-46. MicroRNA NANOCELL THERAPY FOR GLIOBLASTOMA

Therapeutic resistance stemming from inter and intra-tumoral heterogeneity is a significant impediment towards development of effective therapeutics for glioblastoma. We hypothesized that microRNAs can potentially counteract resistance emanating from such heterogeneity as they simultaneously modulat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Babar Khan, Muhammad, Ruggieri, Rosamaria, Tran, Nhan, Sarkaria, Jann, MacDiarmid, Jennifer, Brahmbhatt, Himanshu, Boockvar, John, Symons, Marc
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Abstracts from the 3rd Sno-Scidot Joint Conference on Therapeutic Delivery to the CNS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846215/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1182
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados